Similar articles

• Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.

  Triggle CR, Li YQ, Wyse DG. Triggle CR, et al. Proc West Pharmacol Soc. 1992;35:97-102. Proc West Pharmacol Soc. 1992. PMID: 1502246 No abstract available.
• RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.

  Katz LB, Giardino EC, Salata JJ, Moore JB Jr, Falotico R. Katz LB, et al. J Pharmacol Exp Ther. 1993 Nov;267(2):648-56. J Pharmacol Exp Ther. 1993. PMID: 8246137
• Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.

  Kashiwabara T, Nakajima T, Kasai H, Nakajima S, Izawa T, Ogawa N. Kashiwabara T, et al. Arch Int Pharmacodyn Ther. 1994 Mar-Apr;327(2):175-83. Arch Int Pharmacodyn Ther. 1994. PMID: 7979826
• [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].

  Wu Y, Fang D. Wu Y, et al. Zhonghua Yi Xue Za Zhi. 1992 Mar;72(3):180-3. Zhonghua Yi Xue Za Zhi. 1992. PMID: 1319810 Review. Chinese. No abstract available.
• Smooth muscle K+ channel openers; their pharmacology and clinical potential.

  Weston AH. Weston AH. Pflugers Arch. 1989;414 Suppl 1:S99-105. doi: 10.1007/BF00582256. Pflugers Arch. 1989. PMID: 2674897 Review. No abstract available.